Invenomic Capital Management LP
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 1769456
BOSTON, MA
Position in IOVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,167,595
-$23,651,789 QoQ
Shares Held
1,482,595
-82.5% QoQ
Ownership
0.327%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#35
of 292 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invenomic Capital Management LP holds $6,361,178 across 2 Biotechnology names. IOVA ranks #1 (97.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IOVA |
Iovance Biotherapeutics, Inc.
This page
|
1,482,595 | $6,167,595 | |
| 2 | LEXX |
Lexaria Bioscience Corp.
|
23,046 | $193,583 |
All Filings in IOVA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,167,595 | 1,482,595 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $29,819,384 | 8,495,551 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,649,448 | 11,959,505 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $22,875,289 | 10,541,608 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,266,820 | 8,294,663 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,281,030 | 5,489,799 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $8,562,930 | 1,053,251 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||